Advertisement

In vivo effects of the monoamine oxidase inhibitors Ro 41-1049 and Ro 19-6327 on the production and fate of renal dopamine

  • M. A. Vieira-Coelho
  • M. Helena Fernandes
  • P. Soares-da-Silva
Conference paper
Part of the Journal of Neural Transmission book series (NEURAL SUPPL, volume 41)

Summary

Ro 41-1049 (2 mg/kg), but not Ro 19-6327 (2 mg/kg), was found to reduce (70% to 93% decrease) DOPAC tissue levels in the renal cortex, outer and inner medulla and, to a similar extent, DOPAC concentrations in plasma. This inhibitory effect was, however, not accompained by an increased accumulation of newly-formed dopamine. The results presented show that type A monoamine oxidase is the predominant form of the enzyme involved in the metabolism of renal dopamine and some of the amine which escapes deamination might leave the kidney through the renal vein in the intact from.

Keywords

Monoamine Oxidase Renal Vein Renal Tissue Renal Medulla Outer Medulla 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baines AD, Chan W (1980) Production of urine free dopamine from dopa: a micro-puncture study. Life Sci 26: 253–259.PubMedCrossRefGoogle Scholar
  2. Caramona MM, Soares-da-Silva P (1990) Evidence for an extraneuronal location of monoamine oxidase in renal tissues. Naunyn Schmiedebergs Arch Pharmacol 341: 411–413.PubMedCrossRefGoogle Scholar
  3. Da Prada M, Kettler R, Keller HH, Cesura AM, Richards JG, Marti JS, Muggli-Maniglio D, Kyburz E, Imhof R (1990) From moclobemide to Ro 19-6327 and Ro 41-1049: the development of a new class of reversible, selective MAO-A and MAO-B inhibitors. J Neural Transm [Suppl] 29: 279–292.Google Scholar
  4. Fernandes MH, Soares-da-Silva P (1990) Effects of MAO-A and MAO-B selective inhibitors Ro 41-1049 and Ro 19-6327 on the deamination of newly-formed dopa-mine in the rat kidney. J Pharmacol Exp Ther 255: 1309–1313.PubMedGoogle Scholar
  5. Fernandes MH, Pestana M, Soares-da-Silva P (1991) Deamination of newly-formed dopamine in rat renal tissues. Br J Pharmacol 102: 778–782.PubMedGoogle Scholar
  6. Fernandes MH, Soares-da-Silva P (1992) Type A and B monoamine oxidase activities in the human and rat kidney. Acta Physiol Scand 145: 363–367.PubMedCrossRefGoogle Scholar
  7. Hayashi M, Yamaji Y, Kitajima W, Saruta T (1990) Aromatic L-amino acid decar-boxylase activity along the rat nephron. Am J Physiol 258: F28–F33.PubMedGoogle Scholar
  8. Kopin IJ (1985) Catecholamine metabolism: basic aspects and clinical significance. Pharmacol Rev 37: 333–364.PubMedGoogle Scholar
  9. Pestana M, Soares-da-Silva P (1992) Cell outward transport of renal dopamine and the involvement of type A and B monoamine oxidase. J Am Soc Nephrol 3: 833.Google Scholar
  10. Seri I, Kone BC, Gullans SR, Aperia A, Brenner BA, Ballermann BJ (1990) Influence of Na+ intake on dopamine-induced inhibition of renal cortical Na+-K+-ATPase. Am J Physiol 258: F52–F60.PubMedGoogle Scholar
  11. Siragy HM, Felder RA, Howell NL, Chevalier RL, Peach MJ, Carey RM (1989) Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am J Physiol 257: F469–F477.PubMedGoogle Scholar
  12. Soares-da-Silva P, Fernandes MH (1990) Regulation of dopamine synthesis in the rat kidney. J Auton Pharmacol 10[Suppl 1]: 25–30.CrossRefGoogle Scholar
  13. Youdim MBH, Finberg JPM, Tipton KF (1988) Monoamine oxidase. In: Trendelenburg, U, Weiner N (eds) Catecholamines, vol I. Springer, Berlin Heidelberg New York Tokyo, pp 119–192.Google Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • M. A. Vieira-Coelho
    • 1
  • M. Helena Fernandes
    • 1
  • P. Soares-da-Silva
    • 1
  1. 1.Department of Pharmacology and TherapeuticsFaculty of MedicinePortoPortugal

Personalised recommendations